Alzheimer's disease medication use and adherence patterns by race and ethnicity.

Autor: Olchanski N; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, USA.; Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA., Daly AT; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, USA., Zhu Y; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, USA., Breslau R; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, USA., Cohen JT; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, USA.; Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA., Neumann PJ; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, USA.; Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA., Faul JD; Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, Michigan, USA., Fillit HM; Alzheimer's Drug Discovery Foundation, New York, New York, USA., Freund KM; Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA.; Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, USA., Lin PJ; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, USA.; Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA.

Publikováno v: Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2023 Apr; Vol. 19 (4), pp. 1184-1193. Date of Electronic Publication: 2022 Aug 08.

EE465 Value Estimation of the Diabetes Prevention Program: How Well Does Clinical Trial-Based Cost-Effectiveness Apply to the Real World?

Autor: Olchanski, N., Weidner, S., Cohen, J., Kent, D.M.

Publikováno v: In Value in Health June 2023 26(6) Supplement:S144-S144

The Impact of Broader Value Elements on Cost-Effectiveness Analysis: Two Case Studies.

Autor: Ma S; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA. Electronic address: masy0318@hotmail.com., Olchanski N; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA; Department of Medicine, Tufts University School of Medicine, Boston, MA, USA., Cohen JT; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA; Department of Medicine, Tufts University School of Medicine, Boston, MA, USA., Ollendorf DA; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA; Department of Medicine, Tufts University School of Medicine, Boston, MA, USA., Neumann PJ; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA; Department of Medicine, Tufts University School of Medicine, Boston, MA, USA., Kim DD; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA; Department of Medicine, Tufts University School of Medicine, Boston, MA, USA.

Publikováno v: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2022 Aug; Vol. 25 (8), pp. 1336-1343. Date of Electronic Publication: 2022 Mar 18.

Racial and Ethnic Differences in Hospice Use and Hospitalizations at End-of-Life Among Medicare Beneficiaries With Dementia.

Autor: Lin PJ; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts., Zhu Y; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts., Olchanski N; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts., Cohen JT; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts., Neumann PJ; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts., Faul JD; Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor., Fillit HM; Alzheimer's Drug Discovery Foundation, New York, New York., Freund KM; Center for Health Equity Research, Department of Medicine, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts.

Publikováno v: JAMA network open [JAMA Netw Open] 2022 Jun 01; Vol. 5 (6), pp. e2216260. Date of Electronic Publication: 2022 Jun 01.

EM1 When Are Breakthrough Therapies Cost-Effective?

Autor: Olchanski, N., Lin, P.J., Yeh, D., Kowal, S., Cohen, J.T.

Publikováno v: In Value in Health June 2021 24 Supplement 1:S7-S7